Bausch & Lomb (NYSE:BLCO) fell 5.6% in premarket trading after ending a sales process without finding a buyer. “Taking Bausch ...

Bausch Health Companies Inc.’s years-long process of trying to separate its Bausch + Lomb Corp. eye-care business hit a roadblock Thursday when a potential sale to private equity fell through ...

(Reuters) -Bausch + Lomb will not be taken private at this time, the contact lens maker said on Thursday, sending its ...

Bausch Health Companies (BHC) issued the following update on a potential sale of its subsidiary, Bausch + Lomb Corporation (BLCO), which was ...

Bausch + Lomb announced today that, after engagement with potential buyers, it has no immediate plan to sell. At the end of 2024, the company issued a statement outlining its plans for a potential ...

Bausch + Lomb Corporation (BLCO) is down by 8.45 percent during Thursday's trading, falling $1.56 to $16.19. The stock dropped after ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

VAUGHAN, Ontario - Bausch + Lomb Corporation (NYSE/TSX: BLCO), a prominent eye health company with a market capitalization of $6.25 billion, has announced the conclusion of its search for a ...

After hours: February 7 at 4:03:06 PM EST Loading Chart for BLCO ...